Jame Abraham on the Patient Experience of Scalp Cooling Devices

Video

Jame Abraham on the patient experience during scalp cooling for chemotherapy-induced hair loss.

Jame Abraham, MD, Director of the Breast Oncology Program at Cleveland Clinic Cancer Center discusses the patient experience of scalp cooling devices to prevent chemotherapy-induced hair loss.

Abraham was a researcher on an interim analysis of the Orbis Paxman Hair Loss Prevention System, presented at the recent San Antonio Breast Cancer Symposium, which showed that 50% of patients in the scalp cooling group retained their hair. He expressed that patients with histories of migraines or headaches were excluded from the trial in the worry that they would be unable to tolerate the cold of the device. There was also the issue of the extra time using the device takes. However, if a patient is very concerned about chemotherapy-induced hair loss, Abraham stated that this device was a good intervention.

Recent Videos
Image of a woman with glasses wearing a striped blouse and a black sweater in front of an Oncology Nursing News branded backdrop
Screenshot of Kiah Purcell, MSN, AGPCNP-BC, in a video call with the frame surrounded by an Oncology Nursing News branded border
Photo of Jamie Carroll, APRN, CNP, MSN, from a video call with an Oncology Nursing News branded border around the frame
5 experts in this video
Image of Kayle Freeman, DNP, APRN, FNP-C, in a video call with an Oncology Nursing News border around the frame
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Related Content